文献速递糖尿病

C肽水平对苏格兰1型糖尿病生物资源队列临床结局的长期影响

Long-term Effect of C-Peptide Level on Clinical Outcomes in the Scottish Type 1 Bioresource Cohort.
PubMed 文献 · Diabetes Care · 2026-01-01

本研究基于苏格兰1型糖尿病生物资源队列(SDRNT1BIO)5630例患者,随访中位10.8年,发现基线C肽水平与糖尿病酮症酸中毒、严重低血糖和视网膜病变风险呈负相关,且独立于糖化血红蛋白;与心血管疾病和死亡无关联。

要点

  • 基线C肽水平越高,糖尿病酮症酸中毒、严重低血糖和视网膜病变风险越低。
  • 上述关联在调整时间更新的糖化血红蛋白后仍持续存在。
  • C肽水平与心血管疾病和死亡风险无显著关联。

核心结论

  • C肽水平及其维持对1型糖尿病血糖控制和避免急性及慢性并发症具有重要意义。

研究设计与样本

  • 基于苏格兰1型糖尿病生物资源队列(SDRNT1BIO)的长期随访研究,纳入5630例临床诊断1型糖尿病患者,中位糖尿病病程21年。
  • C肽采用Roche免疫分析法在非定时血样中测定,检测下限为3 pmol/L。
  • 通过电子健康记录链接捕获事件和连续结局,使用Poisson广义线性模型和线性混合模型分析,调整性别、年龄、时间更新的1型糖尿病病程、入组年份及年龄与病程交互作用。

主要发现

  • 基线C肽水平与糖尿病酮症酸中毒(P < 0.0001;事件数=1015)、严重住院低血糖(P = 0.0055;n=539)和 Incident 视网膜病变(P < 0.0001;n=1172)呈负相关。
  • 这些关联在调整时间更新的糖化血红蛋白后仍持续存在。
  • 基线C肽水平与心血管疾病(P = 0.9;n=714)或死亡(P = 0.8;n=566)无关联。
  • 在407例有连续C肽测量的亚组中,随访C肽水平与糖尿病酮症酸中毒风险呈负相关(P < 0.001;n=92),与严重住院低血糖呈边缘关联(P = 0.015;n=28)。

临床怎么用

  • 临床中可关注1型糖尿病患者C肽水平,将其作为评估急性并发症(糖尿病酮症酸中毒、严重低血糖)和视网膜病变风险的参考指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To characterize associations of C-peptide measurements with type 1 diabetes (T1D) complications across long-term clinical follow-up in a large representative population cohort (Scottish Diabetes Research Network Type 1 Bioresource [SDRNT1BIO]). RESEARCH DESIGN AND METHODS: SDRNT1BIO includes people with a clinical diagnosis of T1D who are aged 16 years or older at enrollment. Their median diabetes duration is 21 (interquartile range 11-31) years. C-peptide was measured in an untimed blood sample using the Roche immunoassay with a lower limit of detection of 3 pmol/L. Incident events and continuous outcomes were captured through electronic health record linkage across follow-up. Associations were studied using Poisson generalized linear models and linear mixed models adjusted for sex, age, time-updated T1D duration, year of entry, and age/T1D duration interaction. RESULTS: Participants (n = 5,630) were followed for a median of 10.8 years. Inverse associations were found between baseline C-peptide level and diabetic ketoacidosis (DKA) (P < 0.0001; no. of events = 1,015), severe hospitalized hypoglycemia (SHH) (P = 0.0055; n = 539), and incident retinopathy (P < 0.0001; n = 1,172). These associations persisted when adjusted for time-updated glycosylated hemoglobin. No associations were found between baseline C-peptide levels and cardiovascular disease (P = 0.9; n = 714) or death (P = 0.8; n = 566). In a subset of participants (n = 407) with serial C-peptide measures, follow-up C-peptide level was inversely associated with risk for DKA (P < 0.001; n = 92) and there was a borderline association with SHH (P = 0.015; n = 28). CONCLUSIONS: These data demonstrate the importance of C-peptide level and its maintenance for glycemic control and avoidance of acute and chronic complications of T1D.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Mellor JC, Blackbourn LAK, McGurnaghan SJ, et al. Long-term Effect of C-Peptide Level on Clinical Outcomes in the Scottish Type 1 Bioresource Cohort. Diabetes Care. 2026. PMID: 42274395. doi:10.2337/dc25-1738

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。